D-Dimer Level Not Useful for Ruling Out PE in COVID-19 Patients
Overall, 92.3% of patients had plasma D-dimer levels ≥0.05 µg/mL, including all with and 91.2% without, pulmonary embolism
Related Articles
Researchers Question Credibility of Subgroup Analyses in Cancer Trials – Renal and Urology News
Subgroup analyses in cancer trials may not be credible, and their results should be interpreted with caution, according to researchers.
Adjuvant Pembrolizumab Prolongs Overall Survival in Clear Cell RCC – Renal and Urology News
One in 5 patients treated with adjuvant pembrolizumab experienced serious adverse events, so it remains important to weigh the risk vs benefits of the therapy…
Artificial Intelligence Gaining Greater Acceptance in Health Care – Renal and Urology News
In a national survey, 72% of individuals believe health advice from a computer chatbot is accurate.
COVID-19 mRNA-1273 Vaccine Safety: Adverse Events of Special Interest – Renal and Urology News
Researchers performed a large-scale safety review to identity adverse events of special interested associated with the COVID-19 mRNA-1273 vaccine.
Concomitant Use of SSRIs and Oral Anticoagulants Increases Major Bleeding Risk – Renal and Urology News
Researchers evaluated whether concomitant use of SSRIs and oral anticoagulants is associated with an increased risk for major bleeding in patients with atrial fibrillation.
Hemodialysis History Does Not Impact Peritoneal Dialysis Dropout – Renal and Urology News
Primary reasons for HD to PD switch include vascular access failure, patient preference, social issues, and cardiovascular disease
Standard-Dose DOAC Equally Efficacious as Low-Dose in AF – Renal and Urology News
A study was conducted to compare the safety and effectiveness of different DOAC dosage regimens in patients with AF, high bleeding risk, and low thrombosis…
Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant – Renal and Urology News
Patients with stromal-predominant tumors had the youngest age at diagnosis compared with other histologic subtypes
Prostate Cancer BCR Risk Lower With Neoadjuvant Docetaxel, ADT – Renal and Urology News
The role of neoadjuvant chemohormonal therapy in surgically treated high-risk prostate cancer has been controversial.
Federal Advisory Urges Health Providers to Enhance Cyber Defenses – Renal and Urology News
The average financial impact of a health care breach is now $11 million, which far exceeds the spending required to get proper security, cybersecurity specialist…